Associate Professor, Psychiatry and Human Behavior, Brown University Program in Medicine
Psychiatry
Dr. Teri Pearlstein, MD
|
|
Give Review
Dr. Teri Pearlstein works in the field of Psychiatry. She studied medicine at Mount Sinai School of Medicine. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Teri Pearlstein is a published physician as well. She has 70 publications published. The latest was: Interactive case challenge. Dysphoric disorders in women: a case of premenstrual syndrome. Teri Pearlstein is registered with Medicare.
Publications
- Use of psychotropic medication during pregnancy and the postpartum period.
- Circadian phase shifts and mood across the perinatal period in women with a history of major depressive Disorder: A preliminary communication.
- ISPMD consensus on the management of premenstrual Disorders.
- Analysis of brief screening tools for the detection of postpartum depression: Comparisons of the PRAMS 6-item instrument, PHQ-9, and structured interviews.
- Examination of premenstrual symptoms as a risk factor for depression in postpartum women.
- Psychotropic medications and other non-hormonal treatments for premenstrual Disorders.
- A psychiatric mother-baby day hospital for pregnant and postpartum women.
- The relationship between characteristics of sexual abuse and dissociative experiences.
- Stressors and close relationships during childhood and dissociative experiences in survivors of sexual abuse among inpatient psychiatric women.
- Premenstrual Disorders: bridging research and clinical reality.
- A double-blind, placebo-controlled trial of fluvoxamine in binge eating Disorder: a high placebo response.
- A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.
- Efficacy of sertraline in preventing relapse of posttraumatic stress Disorder: results of a 28-week double-blind, placebo-controlled study.
- Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric Disorder.
- Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention.
- Non-antidepressant treatment of premenstrual syndrome.
- Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
- Is premenstrual dysphoric Disorder a distinct clinical entity?
- Antidepressant treatment of posttraumatic stress Disorder.
- Efficacy and safety of sertraline treatment of posttraumatic stress Disorder: a randomized controlled trial.
- Validation of the structured interview for Disorders of extreme stress.
- Mood Disorders and menopause.
- Affect regulation and suicide attempts in adolescent inpatients.
- A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and Dysthymia.
- The undertreatment of Dysthymia.
- Sertraline in the treatment of premenstrual dysphoric Disorder.
- The relationship between sexual abuse and eating pathology.
- The validation of the Trauma Symptom Checklist-40 (TSC-40) in a sample of inpatients.
- The relationship between dissociative symptoms, alexithymia, impulsivity, sexual abuse, and self-mutilation.
- The long-term sequelae of sexual abuse: support for a complex posttraumatic stress Disorder.
- Validation of the Davidson Trauma Scale in a sample of survivors of childhood sexual abuse.
- Differences in dissociative experiences between survivors of childhood incest and survivors of assault in adulthood.
- Chronicity in posttraumatic stress Disorder (PTSD) and predictors of course of comorbid PTSD in patients with anxiety Disorders.
- Interactive case challenge. Dysphoric Disorders in women: a case of premenstrual syndrome.
- Premenstrual syndrome.
- Dysphoric Disorders in women: a case of perinatal depression.
- Use of dialectical behavior therapy in a partial hospital program for women with borderline personality Disorder.
- Trauma, dissociation, impulsivity, and self-mutilation among substance abuse patients.
- Symptomatic improvement of premenstrual dysphoric Disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative St...
- An affect-management group for women with posttraumatic stress Disorder and histories of childhood sexual abuse.
- Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric Disorder.
- Long-term fluoxetine treatment of late luteal phase dysphoric Disorder.
- Evaluation and treatment of changes in Mood, sleep, and sexual functioning associated with menopause.
- Psychosocial functioning in women with premenstrual dysphoric Disorder before and after treatment with sertraline or placebo.
- Fluoxetine in the treatment of premenstrual syndrome.
- Prevalence of axis I and axis II Disorders in women with late luteal phase dysphoric Disorder.
- Fluoxetine in the treatment of late luteal phase dysphoric Disorder.
- Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy?
- Patient choice of treatment for postpartum depression: a pilot study.
- A preventive intervention for pregnant women on public assistance at risk for postpartum depression.
- Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive Disorder and serotonin reuptake inhibitor treatment.
- Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual Disorders: the ISPMD Montreal consensus.
- Premenstrual dysphoric Disorder: out of the appendix.
- Will oral contraceptives join SSRIs as a first-line treatment option for women with premenstrual dysphoric Disorder?
- Postpartum depression.
- Perinatal depression: treatment options and dilemmas.
- Premenstrual dysphoric Disorder: burden of illness and treatment update.
- Depression and breastfeeding: which postpartum patients take antidepressant medications?
- Low-dose sertraline in the treatment of moderate-to-severe premenstrual syndrome: efficacy of 3 dosing strategies.
- Clinical characteristics of perinatal psychiatric patients: a chart review study.
- Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.
- Treatment of premenstrual dysphoric Disorder with a new drospirenone-containing oral contraceptive formulation.
- Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric Disorder.
- Luteal phase treatment of premenstrual dysphoric Disorder improves symptoms that continue into the postmenstrual phase.
- Pretreatment pattern of symptom expression in premenstrual dysphoric Disorder.
- Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality Disorder.
- Recurrence of symptoms of premenstrual dysphoric Disorder after the cessation of luteal-phase fluoxetine treatment.
- Selective serotonin reuptake inhibitors for premenstrual dysphoric Disorder: the emerging gold standard?
- Review of fluoxetine and its clinical applications in premenstrual dysphoric Disorder.
Schools
New York University School Of Medicine
Mt Sinai Hospital
Procedures Preformed
- Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)
Conditions Treated
- Bipolar Disorder
- Dysthymia and Cyclothymia (Mood Disorders)
- Major Depressive Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Mount Sinai School of Medicine -
NYU School of Medicine
Drug Facts
| NPI NUMBER | 1538185343 | |
| NPPES Provider LastName | PEARLSTEIN | |
| NPPES Provider FirstName | TERI | |
| NPPES Provider ZIPCode | 02904 | |
| NPPES Provider State | RI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 305.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538185343 |
| Last Name Of The Provider | PEARLSTEIN |
| First Name Of The Provider | TERI |
| View All |
Similar Doctors
|
|
Dr. Charles T. Tita, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carmen E. Colomer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thaddeus Shattuck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lowell J. Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary M. Rhodes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharath P. Puttichanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir A. Khan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas J. Scaramella, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin D. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadaf Ali, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neha S. Hudepohl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter D. Kramer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose M. Arvizu Olvera, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa B. Shea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kazi M. Salahuddin, MD
This Doctor is OpenDoctor Recommended.
|